Rett syndrome is a leading cause of postnatal neurodevelopmental regression. Rett syndrome is caused by mutations in MECP2, the gene encoding methyl-CpG binding protein 2. In up to 96% of all classic cases, Rett syndrome cases are caused by mutations or deletions in MECP2. The phenotypic spectrum of MECP2 mutations is broad and includes mental retardation with or without seizures, Angelman syndrome—like phenotype, and autism. Mecp308/Y mice carry a truncating mutation and display many of the features seen in Rett syndrome. Social behavior abnormalities and impaired social interactions in Mecp308/Y mice suggest that MeCP2 plays a role in modulating the activity of genes and neurons important for social interactions. Mice that overexpress MeCP2 at twice the endogenous levels develop a progressive neurologic disorder, demonstrating that MeCP2 levels are tightly regulated and raising the possibility that duplications or gain-of-function mutations of MECP2 might underlie some cases of neurodevelopmental X-linked disorders. (J Child Neurol 2005;20:736—740).
Get full access to this article
View all access options for this article.
References
1.
Rett A.: [On an unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien Med Wochenschr1966;116:723—726.
2.
Hagberg B., et al: A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett syndrome: report of 25 cases. Ann Neurol1983;14(4):471—479.
3.
Hagberg BA, Skjeldal OH: Rett variants: A suggested model for inclusion criteria. Pediatr Neurol1994; 11: 5—11.
4.
Zappella M., Gillberg C., Ehlers S.: The preserved speech variant: A subgroup of the Rett complex: A clinical report of 30 cases. J Autism Dev Disord1998;28:519—526.
5.
Percy AK: Rett syndrome: Current status and new vistas. Neurol Clin2002;20:1125—1141.
6.
Shahbazian MD , Zoghbi HY: Rett syndrome and MeCP2: Linking epigenetics and neuronal function. Am J Hum Genet2002 ;71:1259—1272.
7.
Amir RE, Van den Veyver IB, Wan M., et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpGbinding protein 2. Nat Genet1999 ;23:185—188.
8.
Hendrich B., Bird A.: Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol1998;18:6538—6547.
9.
Lewis JD, Meehan RR, Henzel WJ, et al: Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell1992;69:905—914.
10.
Nan X., Campoy FJ, Bird A.: MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell1997;88:471—481.
11.
Chandler SP , Guschin D., Landsberger N., Wolffe AP: The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA. Biochemistry1999;38:7008—7018.
12.
Amir RE, Van den Veyver IB, Schultz R., et al: Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol2000;47:670—679.
13.
Cheadle JP, Gill H., Fleming N., et al: Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and location . Hum Mol Genet2000;9:1119—1129.
14.
Monros E., Armstrong J., Aibar E., et al: Rett syndrome in Spain: Mutation analysis and clinical correlations . Brain Dev2001;23(Suppl 1):S251—253.
15.
Bienvenu T. , Carrie A., de Roux N., et al: MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet2000;9:1377—1384.
16.
Huppke P., Held M., Hanefeld F., et al: Influence of mutation type and location on phenotype in 123 patients with Rett syndrome. Neuropediatrics2002;33:63—68.
17.
Giunti L., Pelagatti S., Lazzerini V., et al: Spectrum and distribution of MECP2 mutations in 64 Italian Rett syndrome girls: Tentative genotype/phenotype correlation. Brain Dev2001;23 Suppl 1:S242—S245.
18.
Yamada Y., Miura K., Kumagai T., et al: Molecular analysis of Japanese patients with Rett syndrome: Identification of five novel mutations and genotype-phenotype correlation . Hum Mutat2001;18:253.
19.
Chae JH, Hwang YS, Kim KJ: Mutation analysis of MECP2 and clinical characterization in Korean patients with Rett syndrome. J Child Neurol2002;17:33—36.
20.
Leonard H., Colvin L., Christodoulou J., et al: Patients with the R133C mutation: Is their phenotype different from patients with Rett syndrome with other mutations?J Med Genet2003;40:e52.
21.
Smeets E., Terhal P., Casaer P., et al: Rett syndrome in females with CTS hot spot deletions: A disorder profile. Am J Med Genet2005;132:117—120.
22.
Mnatzakanian GN, Lohi H., Munteanu I., et al: A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet2004;36:339—341.
23.
Kriaucionis S., Bird A.: The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res2004;32:1818—1823.
24.
Amir RE, Fang P., Yu Z., et al: Mutations in exon 1 of MECP2 are a rare cause of Rett syndrome . J Med Genet2005;42:e15.
25.
Laccone F., Junemann I., Whatley S., et al: Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. Hum Mutat2004;23:234—244.
26.
Schollen E. , Smeets E., Deflem E., et al: Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: Implications for routine diagnosis of Rett syndrome. Hum Mutat2003;22:116—120.
27.
Wan M., Lee SS, Zhang X., et al: Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum Genet1999;65:1520—1529.
28.
Hoffbuhr K. , Devaney JM, LaFleur B., et al: MeCP2 mutations in children with and without the phenotype of Rett syndrome. Neurology2001;56:1486—1495.
29.
Zappella M. , Meloni I., Longo I., et al: Preserved speech variants of the Rett syndrome: Molecular and clinical analysis. Am J Med Genet2001;104:14—22.
30.
Sirianni N. , Naidu S., Pereira J., et al: Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet1998;63:1552—1558.
31.
Carney RM, Wolpert CM, Ravan SA, et al: Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol2003;28:205—211.
32.
Leonard H., Silberstein J., Falk R., et al: Occurrence of Rett syndrome in boys. J Child Neurol2001;16:333—338.
33.
Schwartzman JS, Bernardino A., Nishimura A., et al: Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics2001;32:162—164.
34.
Clayton-Smith J., Watson P., Ramsden S., Black GC: Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet2000;356:830—832.
35.
Armstrong J. , Pineda M., Aibar E., et al: Classic Rett syndrome in a boy as a result of somatic mosaicism for a MECP2 mutation. Ann Neurol2001;50:692.
36.
Topcu M., Akyerli C., Sayi A., et al: Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet2002 ;10:77—81.
37.
Ravn K., Nielsen JB, Uldall P., et al: No correlation between phenotype and genotype in boys with a truncating MECP2 mutation. J Med Genet2003 ;40:e5.
38.
Couvert P., Bienvenu T., Aquaviva C., et al: MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet2001;10: 941—946.
39.
Imessaoudene B., Bonnefont JP, Royer G., et al: MECP2 mutation in non-fatal, non-progressive encephalopathy in a male. J Med Genet2001 ;38:171—174.
40.
Cohen D., Lazar G., Couvert P., et al: MECP2 mutation in a boy with language disorder and schizophrenia . Am J Psychiatry2002;159:148—149.
41.
Meloni I., Bruttini M., Longo I., et al: A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am J Hum Genet2000;67:982—985.
42.
Yntema HG, Oudakker AR, Kleefstra T., et al: In-frame deletion in MECP2 causes mild nonspecific mental retardation . Am J Med Genet2002;107:81—83.
43.
Orrico A., Lam C., Galli L., et al: MECP2 mutation in male patients with non-specific X-linked mental retardation. FEBS Lett2000;481:285—288.
44.
Klauck SM, Lindsay S., Beyer KS, et al: A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet2002; 70:1034-1037.
45.
Young JI, Zoghbi HY: X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of Rett syndrome. Am J Hum Genet2004;74:511—520.
46.
Moretti P., Bouwknecht JA, Teague R., et al: Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum Mol Genet2005;14:205—220.
47.
Collins AL, Levenson JM, Vilaythong AP, et al: Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet2004;13:2679—2689.
48.
Ariani F., Mari F., Pescucci C., et al: Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: Report of one case of MECP2 deletion and one case of MECP2 duplication. Hum Mutat2004;24:172—177.
49.
Samaco RC, Nagarajan RP, Braunschweig D., LaSalle JM: Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum Mol Genet2004;13:629—639.
50.
Meins M., Lehmann J., Gerresheim F., et al: Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J Med Genet2005;42:e12.
